Checkpoint Therapeutics Overview
- Founded
- 2014

- Status
- Public
- Employees
- 8

- Stock Symbol
- CKPT

- Investments
- 1
- Share Price
- $3.62
- (As of Friday Closing)
Checkpoint Therapeutics General Information
Description
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP).
Contact Information
- 2 Gansevoort Street
- 9th Floor
- New York, NY 10014
- United States
Checkpoint Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.62 | $3.73 | $1.05 - $4.50 | $246M | 67.9M | 681K | -$0.46 |
Checkpoint Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 159,020 | 79,166 | 32,365 | 75,553 |
Revenue | 1,067 | 1,708 | 3,506 | 1,725 |
EBITDA | (21,816) | (24,850) | (36,515) | (22,775) |
Net Income | (21,682) | (24,714) | (36,367) | (22,677) |
Total Assets | 42,645 | 26,966 | 24,899 | 21,413 |
Total Debt | 0 | 0 | 0 | 0 |
Checkpoint Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Checkpoint Therapeutics‘s full profile, request access.
Request a free trialCheckpoint Therapeutics Comparisons
Industry
000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCheckpoint Therapeutics Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Incyte | Corporate Backed or Acquired | Wilmington, DE | 0000 | 00000000000 | ||
00000000 000000000 | Corporation | West Conshohocken, PA | 00 | 000.00 | 000000 - 000 | 000.00 |
000000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000 00000 | |
000000000 00000000 | Venture Capital-Backed | Pittsburgh, PA | 00 | 000.00 | 0000000000 | 000.00 |
000000000 | Formerly VC-backed | South San Francisco, CA | 00000 | 000.00 | 00000000000 |
Checkpoint Therapeutics Executive Team (3)
Checkpoint Therapeutics Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000000 000 | Checkpoint Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
Checkpoint Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCheckpoint Therapeutics Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 (0000000 | 000000000 00000 00 | Buildings and Property |